The combined evaluation ofp53 accumulation and of Ki-67 (MIBI) labelling index provides independent information on overall survival of ovarian carcinoma patients
Open Access
- 1 May 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (5) , 469-476
- https://doi.org/10.1023/a:1008253429700
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Expression and prognostic significance of Bcl-2 in ovarian tumoursBritish Journal of Cancer, 1995
- Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaCancer, 1995
- Proliferating cell nuclear antigen (PCNA) immunostaining - a prognostic factor in ovarian cancer?British Journal of Cancer, 1995
- Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.Journal of Clinical Oncology, 1995
- p53 Expression in Epithelial Ovarian Neoplasms: Relationship to Clinical and Pathological Parameters, Ki-67 Expression and Flow CytometryGynecologic Oncology, 1994
- Prognostic significance of p53 immunostaining in epithelial ovarian cancer.Journal of Clinical Oncology, 1994
- P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significanceEuropean Journal Of Cancer, 1994
- p53 accumulation in ovarian carcinomas and its prognostic implicationsHuman Pathology, 1993
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- Flow cytometric evaluation of epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1990